NCT06634004
Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya
Enrolling by Invitation
Not specifiedAges 18–69ObservationalVanderbilt University Medical CenterInvestigator-initiated
~100 participants
Updated 2026-01-14 on ClinicalTrials.gov
What's tested:BOLD MRI
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Revascularization success
Measured over 6 years
Conditions
Where it's being run
2 sites across 2 statesMaryland1
Tennessee1
Study leadership
- Manus J Donahue, MBA, PhD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Exclusion
Both moyamoya and healthy controls
What this trial measures
- Revascularization success6 years
The outcome measure will be the number of patients with successful surgical revascularization.